# Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis

> **NCT00973817** · PHASE2,PHASE3 · COMPLETED · sponsor: **Vital Therapies, Inc.** · enrollment: 62 (actual)

## Conditions studied

- Acute On Chronic Hepatitis

## Interventions

- **BIOLOGICAL:** ELAD plus standard of care treatment
- **OTHER:** Standard of care

## Key facts

- **NCT ID:** NCT00973817
- **Lead sponsor:** Vital Therapies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-04
- **Final completion:** 2011-05
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2013-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00973817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00973817, "Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00973817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*